首页> 外国专利> NOVEL DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE, OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION

NOVEL DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE, OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION

机译:1,2,3,4-四氢嘧啶{1,2-a}嘧啶-6-一的新衍生物,并据此获悉并应用于医药

摘要

FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to novel compounds of formula (I) or their additive salts with inorganic and organic acids, a method of obtaining thereof and application. The compounds can be used in the treatment of primary tumours and/or metastases, in particular, in case of cancer tumours of the stomach, liver, kidneys, ovaries, large intestine, prostate, endometrium, lungs (NSCLC and SCLC), glioblastomas, cancer tumours of the thyroid gland, urinary bladder, mammary gland, in case of melanomas, in case of lymphoid or myeloid tumours of the haematopoietic system, in case of sarcomas, in case of cancer tumours of the brain, larynx, lymphatic system, cancer tumours of bones and pancreas, in case of hamartomas, as well as in the treatment of malaria. In formula (I),R1 represents -L-aryl or branched -L-heteroaryl, where L represents a simple bond, or a lineaer or branched alkyl, containing from 1 to 6 carbon atoms and having in case of necessity a hydroxygroup, or groups CO or -CO-Alk-; with aryls and hetaroaryls in case of necessity having one or several substituents, which are similar or different and selected from atoms of halogens, alkoxy- and alkyls; with the latter said alkoxy- and alkyls, in turn, having one or several substituents, which are similar or different and selected from atoms of halogens; R2 represents a hydrogen atom or alkyl; R3 represents an alkyl, which has in case of necessity one or several atoms of halogens as substituents; R4 represents a hydrogen atom or a halogen atom; with the term "aryl" standing for phenyl, and the term "heteroaryl" standing for pyridyl or benzothienyl; all the alkyls (alk) and alkoxy, mentioned above, are linear or branched and contain from 1 to 6 carbon atoms.EFFECT: compounds possess properties of the phosphorilation inhibitor AKT(PKB).20 cl, 2 tbl, 56 ex
机译:发明领域本发明涉及式(I)的新型化合物或其与无机酸和有机酸的加成盐,其获得方法和用途。该化合物可用于治疗原发性肿瘤和/或转移瘤,特别是在胃,肝,肾,卵巢,大肠,前列腺,子宫内膜,肺(NSCLC和SCLC),胶质母细胞瘤,甲状腺,膀胱,乳腺的癌症肿瘤,如果是黑色素瘤,如果是造血系统的淋巴样或髓样肿瘤,如果是肉瘤,如果是脑,喉,淋巴系统,癌症等肿瘤骨头和胰腺肿瘤,错构瘤以及治疗疟疾。在式(I)中,R 1表示-L-芳基或支链-L-杂芳基,其中L表示单键,或含1至6个碳原子并且在必要时具有羟基的直链或支链烷基,或CO或-CO-Alk-基团;在必要时具有一个或几个类似或不同的取代基,并选自卤素,烷氧基和烷基的原子的芳基和杂芳基;所述烷氧基和烷基依次具有一个或几个类似或不同的并且选自卤素原子的取代基; R 2代表氢原子或烷基; R 3表示烷基,其在必要时具有一个或多个卤素原子作为取代基; R4代表氢原子或卤素原子;术语“芳基”代表苯基,术语“杂芳基”代表吡啶基或苯并噻吩基;上述所有烷基(烷)和烷氧基均为直链或支链且含有1-6个碳原子。效果:化合物具有磷化抑制剂AKT(PKB)的性质.20 cl,2 tbl,56 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号